Molecular Templates, Inc. (MTEM)

USD 0.0

(0.0%)

Revenue Summary of Molecular Templates, Inc.

  • Molecular Templates, Inc.'s latest annual revenue in 2023 was 57.3 Million USD , up 190.1% from previous year.
  • Molecular Templates, Inc.'s latest quarterly revenue in 2024 Q2 was 572 Thousand USD , down -94.84% from previous quarter.
  • Molecular Templates, Inc. reported a annual revenue of 19.75 Million USD in annual revenue 2022, down -48.95% from previous year.
  • Molecular Templates, Inc. reported a annual revenue of 38.69 Million USD in annual revenue 2021, up 147.5% from previous year.
  • Molecular Templates, Inc. reported a quarterly revenue of 572 Thousand USD for 2024 Q2, down -94.84% from previous quarter.
  • Molecular Templates, Inc. reported a quarterly revenue of 57.3 Million USD for 2023 FY, up 190.1% from previous quarter.

Annual Revenue Chart of Molecular Templates, Inc. (2023 - 2002)

Historical Annual Revenue of Molecular Templates, Inc. (2023 - 2002)

Year Revenue Revenue Growth
2023 57.3 Million USD 190.1%
2022 19.75 Million USD -48.95%
2021 38.69 Million USD 147.5%
2020 15.63 Million USD -19.82%
2019 19.49 Million USD 167.73%
2018 7.28 Million USD 202.45%
2017 2.4 Million USD 28.09%
2016 1.88 Million USD -97.56%
2015 76.91 Million USD 422.45%
2014 14.72 Million USD 17.82%
2013 12.49 Million USD 112.97%
2012 5.86 Million USD 9362.9%
2011 62 Thousand USD 0.0%
2010 - USD -100.0%
2009 1.44 Million USD 0.0%
2008 1.44 Million USD 0.28%
2007 1.43 Million USD -1.71%
2006 1.46 Million USD 111.74%
2005 690 Thousand USD 0.0%
2004 - USD 0.0%
2003 - USD 0.0%
2002 - USD 0.0%

Peer Revenue Comparison of Molecular Templates, Inc.

Name Revenue Revenue Difference
America Great Health 204.3 Thousand USD -27948.828%
Ampio Pharmaceuticals, Inc. - USD -Infinity%
Aridis Pharmaceuticals, Inc. - USD -Infinity%
Biora Therapeutics, Inc. 4000.00 USD -1432550.0%
Bio-Path Holdings, Inc. - USD -Infinity%
Better Therapeutics, Inc. - USD -Infinity%
Calithera Biosciences, Inc. - USD -Infinity%
Comera Life Sciences Holdings, Inc. 633.1 Thousand USD -8951.622%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. - USD -Infinity%
Eloxx Pharmaceuticals, Inc. - USD -Infinity%
Evelo Biosciences, Inc. - USD -Infinity%
Evolutionary Genomics, Inc. - USD -Infinity%
Finch Therapeutics Group, Inc. 107 Thousand USD -53457.009%
Galera Therapeutics, Inc. - USD -Infinity%
Innovation1 Biotech Inc. - USD -Infinity%
Kiromic BioPharma, Inc. - USD -Infinity%
Navidea Biopharmaceuticals, Inc. 65.65 Thousand USD -87187.516%
NexImmune, Inc. - USD -Infinity%
Orgenesis Inc. 530 Thousand USD -10712.453%
Panbela Therapeutics, Inc. - USD -Infinity%
Point of Care Nano-Technology, Inc. - USD -Infinity%
PaxMedica, Inc. Common Stock - USD -Infinity%
Scopus BioPharma Inc. - USD -Infinity%
Sorrento Therapeutics, Inc. 62.83 Million USD 8.805%
Statera Biopharma, Inc. - USD -Infinity%
TRACON Pharmaceuticals, Inc. 12.04 Million USD -375.766%
Trevena, Inc. 3.12 Million USD -1733.792%
Vaxxinity, Inc. - USD -Infinity%
Vaccinex, Inc. 570 Thousand USD -9953.684%
Vicapsys Life Sciences, Inc. - USD -Infinity%
Viracta Therapeutics, Inc. - USD -Infinity%
ZIVO Bioscience, Inc. 27.65 Thousand USD -207154.973%